ASSESSING THE QUALITY OF QUALITY OF LIFE MEASURES IN HEART FAILURE- A COMPARISON OF AVAILABLE INSTRUMENTS

Author(s)

Herdman M1, Garin O1, Vilagut G1, Ribera A2, Permanyer-Miralda G2, Ferrer M3, Rajmil L4, Valderas JM5, Alonso J31CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Cataluña, Spain, 2Hospital Vall d'Hebrón, Barcelona, Cataluña, Spain, 3Institut Municipal d'Investigació Mèdica, Barcelona, Cataluña, Spain, 4Catalan Agency for Health Technology Assessment and Research, Barcelona, Cataluña, Spain, 5University of Manchester, Manchester, United Kingdom

OBJECTIVES: To evaluate and compare the performance of available disease-specific health-related quality of life (HRQL) instruments for use in heart failure. METHODS:  A systematic review identified 5 disease-specific HRQL questionnaires for use in heart failure (Minnesota Living with Heart Failure questionnaire [MLHFQ], Chronic Heart Failure questionnaire [CHFQ], Kansas City Cardiomyopathy questionnaire [KCCQ], Left Ventricular Disease Questionnaire [LVDQ], and the Quality of Life in Severe Heart Failure Questionnaire [QLSHFQ]). The 5 questionnaires were evaluated using EMPRO (Evaluating Measures of Patient Reported Outcomes), a tool for the standardized assessment of the psychometric properties and usability of patient reported outcome measures. Groups of four expert appraisers evaluated 8 attributes for each instrument and gave an overall recommendation after a consensus procedure. Scores ranged from 0 (worst possible score) to 100 (best possible score). Inter-rater agreement (intra-class correlation coefficient – ICC) was analyzed and median scores and ranges for all EMPRO attributes were calculated. An overall recommendation was provided (highly recommended, recommended with provisos, not recommended, unsure). RESULTS: Inter-rater agreement for EMPRO was generally acceptable (ICC of 0.48 - 0.93 for individual attributes). Median overall EMPRO ratings and attribute score ranges were: MLHFQ (59.8, 33.3–69.4), CHFQ (54.9, 38.1–72.2), KCCQ (47.2, 38.1–100), LVDQ (47.7, 11.1–76.7), and QLSHFQ (7.7, 5.6–26.6). The highest scores for all instruments except the QLSHFQ were on responsiveness (median scores from 5.6 to 100). Three of the questionnaires (MLHFQ, CHFQ, KCCQ) were recommended with provisos; the LVDQ and QLSHFQ were not recommended. CONCLUSIONS: Of the 5 instruments evaluated, 2 (MLHFQ, CHFQ) scored well on EMPRO and were recommended, whilst the others may be limited to use in particular types of study or require further investigation. This type of assessment can provide useful information for questionnaire selection. Funding: This work was supported by grants from Instituto de Salud Carlos III FEDER, (PI08/90724).

Conference/Value in Health Info

2009-10, ISPOR Europe 2009, Paris, France

Value in Health, Vol. 12, No. 7 (October 2009)

Code

PCV142

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×